Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT with or without PD-1 inhibitor for unresectable colorectal cancer liver metastases
ChiCTR2300076051Phase 2Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 2 trial of Placebo-COD Research Private Ltd in colorectal cancer (CRC) (2 arms), sponsored by Shanghai East Hospital. Primary endpoint: Local control and survival rates. Started Jul 2022; status: recruiting.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2300076051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076051.